Apnimed, Inc. Common Stock (APMD NASDAQ) stock market data APIs
$27.4196
0.09(0.3%)
as of September 4, 2026
Try our APIs with
free plan!
Apnimed, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Prev. Close
27.4196
Open
27.4886
High
28.2137
Low
26.1914
52 wk Range
16-35.29
Market Cap
1 143 M
P/E Ratio
11.39
Shares Outstanding
41 623 K
Revenue
120 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Apnimed, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Apnimed, Inc. Common Stock data using free add-ons & libraries
Get Apnimed, Inc. Common Stock Fundamental Data
Apnimed, Inc. Common Stock Fundamental data includes:
- Net Revenue: 120 M
- EBITDA: 41 364 K
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Apnimed, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Apnimed, Inc. Common Stock News
New
Moderna Stock Carries A Market Value Its Revenue Does Not Support
Photo by geralt on Pixabay Moderna's commercial business has shrunk and is lossmaking, which puts the weight of its market value on a pipeline rather than on revenue. Moderna (MRNA) has returned abo...
Apnimed (APMD) Joins The NASDAQ Composite Index
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Apnimed (NasdaqGS:APMD) has been added to the NASDAQ Composite Index, increasing its visibi...
Stock Market, IPO Leaders Rally To New Highs. Check This Screen Daily.
Stock market leaders are becoming plentiful as the S&P 500 probes all-time highs. Recent IPO Bending Spoons clears an IPO base. Continue Reading
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commerciali...
Get Apnimed, Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
